Redsense to exhibit at the 60th ERA Congress Milan 2023

Redsense Medical announces that the company will exhibit on the this year's ERA conference in Milan, June 15-18.

The European Renal Association (ERA) organizes the largest annual nephrology congress in Europe. The 60th ERA Congress will be held as a hybrid event in Milan on June 15-18, 2023, and will host thousands of attendees from around the world.

Redsense will have exhibition booth E.220. where they will showcase and promote the Redsense product range. 

For in-depth information about the ERA-EDTA event, please see the official website:
https://www.era-online.org/events/milan-2023/

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.